跳至主要内容
临床试验/ISRCTN41705277
ISRCTN41705277已完成未知

The effect of muscle relaxant drugs on the larynx

HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 40 人开始时间: 2004年1月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Phase 1: 40 patients will be studied in this randomised crossover study. All patients will be scheduled to undergo elective surgery which will require the use of nondepolarizing muscle relaxants.
  • Phase 2: American Society of Anesthesiologists (ASA) 1&2 patients will be studied initially. Inclusion and exclusion criteria and patient monitoring will be as for Phase 1. Patients will then be allocated randomly to receive one of five muscle relaxants (10 per group). If numbers prove insufficient, further patients will be recruited, in groups of 25 (5 per group).

排除标准

  • Any patient with a history of regurgitation, dyspepsia or neuromuscular disease or who is taking any medication that may interfere with neuromuscular function will be excluded.

研究者

发起方
HS R&D Regional Programme Register - Department of Health (UK)

相似试验